VIEWPOINTS


Viewpoints are a collection of news and opinion articles that capture key research developments and important issues in the field of oncology.


Nutritional Challenges in Patients Post-Whipple Surgery

Nutritional Challenges in Patients Post-Whipple Surgery

Nutrition is a critical factor to consider both in the pre- and postoperative period for patients undergoing a Whipple procedure.

Random Mutations May Be Leading Cause of Oncogenesis

Random Mutations May Be Leading Cause of Oncogenesis

According to a study across all 32 cancer types, data suggest that 66% of mutations leading to cancer are the result of random events.

Bladder Cancer Treatment Is Being Revolutionized by Immunotherapy

Bladder Cancer Treatment Is Being Revolutionized by Immunotherapy

Clinical trials and drug approvals in the past several years have dramatically improved bladder cancer treatment.

Periodontal Disease: A Risk Factor for Non-Hodgkin Lymphoma?

Periodontal Disease: A Risk Factor for Non-Hodgkin Lymphoma?

More studies are needed to determine the association between periodontal disease and non-Hodgkin lymphoma.

Maintenance Rituximab for Follicular Lymphoma

Maintenance Rituximab for Follicular Lymphoma

A recent meta-analysis including patients from 7 trials shows that MR improves overall survival among all patients regardless of patient and disease characteristics.

Proposed US Budget Cuts: Effects on Cancer Research

Proposed US Budget Cuts: Effects on Cancer Research

According to the AACI, proposed budget cuts by the White House would likely mean a cut of close to $1 billion for the National Cancer Institute.

Managing Gastrinomas: Evaluating Treatment Options

Managing Gastrinomas: Evaluating Treatment Options

Gastrinomas, rare endocrine tumors, can be treated in multiple ways, regardless of whether the tumor is resectable.

Meta-analysis Outlines Efficacy of Treatments for Relapsed/Refractory Multiple Myeloma

Meta-analysis Outlines Efficacy of Treatments for Relapsed/Refractory Multiple Myeloma

A meta-analysis found that the "best treatment" for prolonging PFS in R/R MM was daratumumab, lenalidomide, and dexamethasone.

Non-invasive Biomarkers for Metastatic Prostate Cancer

Non-invasive Biomarkers for Metastatic Prostate Cancer

Can liquid biopsy and molecular imaging biomarkers help inform more precise management of patients with metastatic prostate cancer?

Ibrutinib for the Relief of GVHD-related Symptoms

Ibrutinib for the Relief of GVHD-related Symptoms

Ibrutinib shows promise for reducing the severity of symptoms and steroid dose related to cGVHD, particularly after systemic therapy.

Treeomics: A Mathematical Tool for Predicting Metastases

Treeomics: A Mathematical Tool for Predicting Metastases

Researchers recently created a tool, Treeomics, to reconstruct the evolutionary pathway of metastases and to chart subclones to their anatomical locations.

The Rising Trend of Colorectal Cancer in Young Adults

The Rising Trend of Colorectal Cancer in Young Adults

Compared with adults born in around 1950, those born around 1990 are at a 2-fold higher risk for colon cancers and a 4-fold higher risk for rectal cancers.

Searching for a Connection Between Multiple Myeloma and Autoimmune Disease

Searching for a Connection Between Multiple Myeloma and Autoimmune Disease

A number of studies have attempted to determine whether multiple myeloma is directly linked to autoimmune disease.

Bendamustine-triplet in Front-line Multiple Myeloma

Bendamustine-triplet in Front-line Multiple Myeloma

The combination of bendamustine, bortezomib, and dexamethasone was reported to be effective in achieving overall response rates in myeloma.

Weight Gain: A Risk Factor for Postmenopausal Breast Cancer

Weight Gain: A Risk Factor for Postmenopausal Breast Cancer

While women who lost more than 5 kg after age 18 were at a 23% reduced risk for breast cancer, those who gained more than 30 kg were at a 32% increased risk.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters